To own Kraken Robotics, you need to believe that demand for subsea sensors, batteries and survey services can support consistent use of its expanded capacity and contract backlog. The Q2 2026 update, with Covelya folded into the order book, keeps that big picture intact. The key near term catalyst is simple: how quickly that enlarged backlog turns into recognised revenue.
The biggest current risk is execution. Kraken Robotics is integrating Covelya on top of prior deals like 3D at Depth, while also managing large, timing sensitive defense and offshore contracts. Any delay in project delivery or integration hiccups could slow revenue conversion and keep profitability under pressure, even with a solid book of committed work.
Among recent developments, the planned addition of the Covelya Group stands out as most relevant to this quarter. It plugs more sonar, navigation and positioning capability into the Kraken Robotics toolkit. That matters directly for the Q2 story because those Covelya orders are now part of the backlog that investors are watching for conversion into sales.
This acquisition also ties into the main catalysts around defense UUV spending and offshore survey work. A broader product set can support cross selling across shared military and commercial customers, but it also raises the bar on integration risk that analysts have highlighted. Your thesis probably hinges on whether management can execute on that mix shift without letting project timing or margins slip meaningfully.
Consensus forecasts put Kraken Robotics on a much larger footing by the end of the decade, with analysts assuming revenues reach CA$1.0b and earnings climb to CA$147.1m by 2029. Those projections sit on top of an aggressive revenue growth assumption of 109.7% a year over the next three years, off a base where the business is still reporting a loss of CA$7.5m today.
On that path, profit margins are expected to move from a loss position of 6.9% today to a margin of 14.7% in roughly three years. That kind of swing would mean Kraken Robotics would not only be growing quickly; it would also be expected to convert a higher share of those sales into profit as integration work on 3D at Depth and Covelya, higher battery output and defense contracts flow through.
To square those earnings projections with current pricing, the consensus framework uses 2029 earnings of CA$147.1m and a P/E multiple of 25.5x, which is above the 23.5x level cited for the wider Canadian electronic peer group. Analysts also factor in modest share count expansion of 0.38% a year over the next three years and apply an 8.0% discount rate to bring those longer dated cash flows back to today.
Against a current share price of CA$5.10, the CA$9.58 average target implies a 46.8% gap to where analysts think the stock could trade if those 2029 metrics are met. The spread between the most optimistic CA$13.00 target and the most cautious CA$5.00 view underlines how much of the Kraken Robotics debate comes down to your own confidence in rapid revenue growth, margin expansion and clean execution on the enlarged backlog.
Kraken Robotics' narrative projects CA$1.0b revenue and CA$147.1m earnings by 2029. This assumes 109.7% yearly revenue growth and an earnings increase of about CA$154.6m from a loss of CA$7.5m today.
Uncover why Kraken Robotics' fair value indicates a 92% potential upside to its current price as investors reassess how quickly that discount could close.
For Kraken Robotics, the bullish twist is backlog quality. The most optimistic analysts were already pencilling in about CA$895.0m of 2029 revenue and CA$128.4m in earnings before this Q2 update and Covelya order book detail. You might see this quarter and wonder whether those pre news assumptions now look cautious or stretched.
Explore 9 other Kraken Robotics fair value estimates, including one that suggests potential upside of as much as 171% from the current price!
Don't just follow the ticker. Dig into the data and build a conviction that's truly your own.
Once you have formed a view on Kraken Robotics, it can help to cross check that thinking against other opportunities with different risk and return profiles. The Simply Wall St Screener lets you scan for stocks that fit your preferred mix of quality, balance sheet strength and income potential in just a few clicks.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com